New Enterprise Associates

New Enterprise Associates, Inc. is a private equity and venture capital firm established in 1977 and headquartered in Menlo Park, California, with additional offices in India and China. The firm specializes in investments across various stages of company development, including seed, start-up, early stage, and later stage, with a focus on sectors such as information technology, healthcare, and energy technology. NEA's investment strategy encompasses a wide range of industries, including consumer internet, software, biotechnology, medical devices, and alternative energy. With over $19 billion in cumulative committed capital, the firm has a notable track record, having participated in more than 210 portfolio company IPOs and over 360 acquisitions. NEA aims to invest between $0.05 million and $20 million, targeting both domestic and international markets, particularly in Asia and the Americas.

Michael James Barrett

Partner Emeritus

Kate Barrett

Marketing Partner

Peter J. Barris

Chairman

Ronald D. Bernal

Venture Partner

Ron Bernal

Venture Partner

Tak Cheung

Partner

Philip Chopin

Managing Director

Louis Citron

Chief Administrative Officer and Chief Legal Officer

Robert Croce

Venture Advisor

Bala Deshpande

Sr. Managing Director, India

Lexi Eisenberg

Associate

Anthony A. Florence

Managing General Partner, Technology

Tony Florence

General Partner

Carol Gallagher

Advisor

Tracy Howe

Investment Professional

Suzanne Hooper King

Partner

Liza Landsman

General Partner

Michael Li

Investor

Tiffany Luck

Partner

Joshua Makower

General Partner

Edward T. Mathers

Partner

John Nehra

Retired Special Partner

Michael D. O'Dell

Venture Partner

Santhosh Palani

Principal

Greg Papadopoulos

Venture Partner

Michele Park

Partner

Arno Allan Penzias

Venture Advisor

Eugene A. Trainor

COO

James G. Treybig

Venture Advisor

Paul Walker

General Partner

Harry Weller

Former General Partner

Past deals in US East Coast

Flox

Series A in 2023
Flox is taking nix to work for building software and managing development environments.

X4 Pharmaceuticals

Post in 2022
X4 Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, focused on developing innovative therapeutics for primary immune deficiencies and cancer. The company's lead drug candidate, mavorixafor, is an oral small molecule antagonist of the CXCR4 chemokine receptor, currently undergoing various clinical trials. Mavorixafor is in Phase III trials for treating patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome, and is also being tested in Phase Ib trials for severe congenital neutropenia and Waldenström macroglobulinemia, alongside a Phase IIa trial for clear cell renal cell carcinoma. Additionally, X4 Pharmaceuticals is advancing X4P-002, aimed at treating glioblastoma multiforme, and is developing X4P-003 for primary immune deficiencies. The company has established a license agreement with Abbisko Therapeutics to explore the use of mavorixafor in combination with checkpoint inhibitors for oncology applications. Founded in 2014, X4 Pharmaceuticals was previously known as Arsanis, Inc. before rebranding in March 2019.

Narmi

Series B in 2022
Narmi Inc. is a technology company that specializes in developing online and mobile banking applications for regional and community financial institutions in the United States. Founded in 2016 and headquartered in New York City, Narmi aims to enhance the banking experience by providing a platform that allows these institutions to attract, engage, and retain customers more effectively. Their offerings include features such as online banking, account opening with fraud protection, and multi-factor authentication, all designed to streamline financial transactions and improve customer interaction. By equipping regional and community banks with advanced technology, Narmi helps them compete against larger banks and FinTech companies, fostering a more diverse and engaging financial ecosystem. In addition to its banking applications, Narmi also provides website design, development, and hosting services, as well as content generation and management solutions.

Nodar

Series A in 2022
Nodar, Inc. specializes in manufacturing advanced sensors for various transportation modes, including cars, trucks, drones, ships, trains, and aircraft. The company offers innovative LiDAR technology and a 3D stereo vision system called Nodar Longbow, which is designed to enhance the capabilities of autonomous vehicles. Founded in 2018 and based in Boston, Massachusetts, Nodar aims to provide a cost-effective and high-performance solution for the automotive, marine, and railway industries. Their products, including the Hammerhead system, utilize off-the-shelf cameras to deliver precise depth sensing, targeting applications for level 3 and level 4 autonomous vehicles. This technology supports functions such as collision warning, path planning, and automatic emergency braking, contributing to improved safety and performance in the automotive sector.

Trevi Therapeutics

Post in 2022
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in New Haven, Connecticut, dedicated to developing and commercializing nalbuphine ER, an investigational therapy. The company's lead product, Haduvio, is an oral extended-release formulation of nalbuphine currently undergoing Phase IIb/III clinical trials. Trevi Therapeutics is focused on addressing serious neurologically mediated conditions, including chronic pruritus, chronic cough associated with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in Parkinson's disease patients. The ongoing PRISM trial evaluates Haduvio's effectiveness in treating severe pruritus related to prurigo nodularis, highlighting its potential in managing conditions linked by a common pathophysiology involving opioid receptors in the nervous system. Founded in 2011, Trevi Therapeutics aims to provide innovative therapeutic solutions for patients with significant unmet medical needs.

hOS

Seed Round in 2022
HOS is an AI technology company that develops scalable technologies to achieve significant and constructive changes in the world.

Neo Cybernetica

Seed Round in 2022
Neo Cybernetica specializes in the development of cybernetics technology aimed at enhancing the capabilities of artificial intelligence systems. By leveraging advanced communication and automatic control systems, the company focuses on creating AI systems that can operate independently as well as collaborate effectively with humans. This innovative approach positions Neo Cybernetica to address future opportunities and challenges, ultimately contributing to the advancement of AI technologies that can benefit society in the coming decades.

Proof of Learn

Seed Round in 2022
Proof of Learn (POL) is a blockchain start-up Web3 education platform.

Korro Bio

Series B in 2022
Korro Bio Inc. specializes in the development of nucleic acid-based therapeutics aimed at targeting specific sequences in genetic code, with a focus on treating rare diseases. Founded in 2018 and located in Cambridge, Massachusetts, the company utilizes a proprietary platform that enables efficient and selective RNA editing by leveraging natural processes found in multi-cellular organisms. This innovative approach allows Korro Bio to edit messenger RNA and recode specific codons, facilitating targeted modifications in protein structure and function across various tissues.

Block Renovation

Series C in 2021
Block Renovation is a renovation platform that combines architect-grade design, construction labor, and materials into a streamlined renovation experience. Block’s mission is to give homeowners a better way to improve the spaces they live in, and to give contractors a better way to work. Founded by Koda Wang and Luke Sherwin, Block simplifies a complex and convoluted process and delivers an intuitive experience for completing a beautiful home renovation.

Candy

Series A in 2021
Candy is a multifaceted company that operates in the digital collectible and confectionery sectors. It develops sports and culture digital assets, providing authentic digital experiences that engage fans and connect them with their interests. Additionally, Candy.com serves as an online retailer catering to the growing demand for bulk, gourmet, and gift confectionery products, offering competitive pricing, expedited shipping, and a unique shopping experience. Furthermore, Candy Digital specializes in non-fungible tokens (NFTs), enabling fans to buy and trade officially licensed tokens related to Major League Baseball. Launched in 2021, this segment of the business was established by notable figures in the industry and reflects Candy's commitment to integrating technology with fan engagement.

Clarifai

Series C in 2021
Clarifai, Inc. specializes in advanced image recognition technology, allowing users to detect near-duplicates and conduct visual searches. The company's systems can identify various categories, objects, and tags within images, enabling the discovery of similar images in large, uncategorized repositories through a combination of semantic and visual similarity. Additionally, Clarifai offers Labeler, a tool designed for labeling unstructured datasets, facilitating data search using artificial intelligence, training AI models, and auto-scaling models in production. Founded in 2013, Clarifai is headquartered in New York, with an additional office in Tallinn, Estonia.

Wizard

Series A in 2021
Wizard is a software development company that offers B2B solutions for brands to sell and market products directly through text.

IonQ

Post in 2021
IonQ, Inc. specializes in the development of general-purpose quantum information computers, utilizing a unique trapped ion approach. The company's technology combines high physical performance, perfect qubit replication, and optical networkability, enabling the creation of scalable quantum computers that surpass the limitations of classical computing. These advancements leverage phenomena such as superposition and entanglement, which are critical at the atomic scale. Founded in 2015 and headquartered in College Park, Maryland, IonQ aims to support a wide range of applications across various industries with its powerful and versatile quantum computing solutions.

Airspan Networks

Post in 2021
Airspan Networks Inc. is a global provider of 4G broadband wireless products and solutions, delivering high-speed data, voice, and multimedia services across various sectors. The company's offerings include a range of advanced technologies, such as AirVelocity for indoor LTE networks, AirSynergy for outdoor urban environments, and AirHarmony for heterogeneous network deployments. Additionally, Airspan provides solutions like Air4G, which integrates LTE and WiMAX technologies, and AirSymphony, a virtual RAN platform for cloud-based LTE networks. Their products operate in licensed and unlicensed frequency bands from 700MHz to 6GHz and are utilized by over 500 operators in more than 100 countries, serving markets such as smart utilities, public safety, and transportation. Airspan also offers network management and support services, ensuring effective deployment and operation of its systems. Founded in 1992, the company is headquartered in Boca Raton, Florida.

Block Renovation

Series B in 2021
Block Renovation is a renovation platform that combines architect-grade design, construction labor, and materials into a streamlined renovation experience. Block’s mission is to give homeowners a better way to improve the spaces they live in, and to give contractors a better way to work. Founded by Koda Wang and Luke Sherwin, Block simplifies a complex and convoluted process and delivers an intuitive experience for completing a beautiful home renovation.

Aetion

Series C in 2021
Aetion, Inc. develops a science and analytics platform to assess real-world evidence (RWE) from a range of sources. The company offers Aetion Evidence Platform, a platform that generates RWE needed by healthcare decision makers to engage in value-based care. Its solution allows payers, providers, medical device makers, biopharma customers, and academic institutions to analyze data from various clinical and financial interactions in healthcare, including claims, electronic health records, registries, and clinical trials. The company’s platform is also used in database analytics and comparative effectiveness courses taken by epidemiologists, outcomes researchers, health economists, and biostatisticians. It serves customers worldwide. Aetion, Inc. has a strategic collaboration with McKesson. The company was founded in 2012 and is based in New York, New York.

Arcellx

Series C in 2021
Arcellx is a privately held development-stage company founded in 2015 and located in Montgomery County, Maryland. The Arcellx team is devoted to providing patients with superior immune cell therapies through scientific innovation, accelerated development, and responsible patient care. Although our initial clinical focus is cancer therapy, we are committed to extending our Antigen- Receptor Complex T cell (ARC-T) therapies across a broad spectrum of human disease.

ThreatQuotient

Venture Round in 2021
ThreatQuotient is a threat intelligence platform (TIP) that centrally manages and correlates unlimited external sources with all internal security and analytics solutions for contextual, operationalized intelligence in a single pane of glass. ThreatQ is also the first TIP to provide Indicator Nurturing, which goes beyond enrichment to help customers tailor indicators of compromise (IOCs) more specifically to their infrastructure. Headquartered in Northern Virginia, ThreatQuotient was founded in 2013 by two former security operations analysts to provide organizations the ability to correlate with confidence.

ThreatQuotient

Debt Financing in 2021
ThreatQuotient is a threat intelligence platform (TIP) that centrally manages and correlates unlimited external sources with all internal security and analytics solutions for contextual, operationalized intelligence in a single pane of glass. ThreatQ is also the first TIP to provide Indicator Nurturing, which goes beyond enrichment to help customers tailor indicators of compromise (IOCs) more specifically to their infrastructure. Headquartered in Northern Virginia, ThreatQuotient was founded in 2013 by two former security operations analysts to provide organizations the ability to correlate with confidence.

Spokn

Seed Round in 2021
Spokn helps companies develop their talent and build a culture of continuous learning - all in audio. Our 'bite-sized' insights cover skills like communication, collaboration, productivity and leadership and come from the top experts in the world - from Harvard Business School and MIT to HubSpot, Mindful, the Financial Times and more. The best part? It's 100% in audio, so learning fits into the daily routine of employees.

Spokn

Seed Round in 2021
Spokn helps companies develop their talent and build a culture of continuous learning - all in audio. Our 'bite-sized' insights cover skills like communication, collaboration, productivity and leadership and come from the top experts in the world - from Harvard Business School and MIT to HubSpot, Mindful, the Financial Times and more. The best part? It's 100% in audio, so learning fits into the daily routine of employees.

WireWheel

Series B in 2021
WireWheel, Inc. is a software company that specializes in data privacy management, offering a cloud-based platform designed to assist organizations in complying with various data protection regulations, such as the EU GDPR, Privacy Shield, PCI DSS, and HIPAA. Founded in 2016 and headquartered in Arlington, Virginia, WireWheel's platform provides tools for privacy program management and subject rights request management. By integrating machine learning and data science, the platform helps companies automate the mapping of their public cloud assets and manage third-party relationships. This capability enables organizations to effectively address their compliance obligations while maximizing the potential of their data assets, ultimately enhancing their competitive advantage in the market.
Personal Genome Diagnostics develops a patient-specific analysis of the cancer genome by using advanced tools and technologies. They were the first to sequence and analyze whole human cancer exomes and subsequently identified many alterations responsible for the development of cancer. They have described the principles underlying the genetic basis of human cancer and have developed novel technologies for non-invasive “liquid biopsy” approaches in cancer. Through PGDx, our founders bring their proprietary methods and expertise to research teams worldwide. The services help oncologists and translational scientists sequence and analyze cancer genomes and identify mutations to characterize aspects of the disease. Their expertise in genome analysis ranges from sample preparation and sequencing to data interpretation and analysis. They specialize in high-throughput next-generation sequencing and proprietary algorithms to identify alterations in complex cancer genomes and have developed novel technologies for non-invasive “liquid biopsy” approaches in cancer. Personal Genome Diagnostics was founded in 2010 and is based in Baltimore, Maryland, United States.

Narmi

Series A in 2021
Narmi Inc. is a technology company that specializes in developing online and mobile banking applications for regional and community financial institutions in the United States. Founded in 2016 and headquartered in New York City, Narmi aims to enhance the banking experience by providing a platform that allows these institutions to attract, engage, and retain customers more effectively. Their offerings include features such as online banking, account opening with fraud protection, and multi-factor authentication, all designed to streamline financial transactions and improve customer interaction. By equipping regional and community banks with advanced technology, Narmi helps them compete against larger banks and FinTech companies, fostering a more diverse and engaging financial ecosystem. In addition to its banking applications, Narmi also provides website design, development, and hosting services, as well as content generation and management solutions.

New Wave Foods

Series A in 2021
New Wave Foods, Inc. specializes in producing and selling plant-based seafood products, focusing primarily on sustainable shrimp alternatives. Founded in 2015 and headquartered in San Francisco, California, the company offers a variety of items, including sautéed, grilled, breaded, and fried shrimp, as well as shrimp tacos and salads. Its products are made from sustainably sourced seaweed and soy protein, enriched with natural flavors and essential amino acids, providing a healthy, low-calorie, and zero-cholesterol option for consumers. Targeting the culinary market in the United States, New Wave Foods aims to preserve and enrich seafood traditions through its innovative plant-based offerings.

Korro Bio

Series A in 2020
Korro Bio Inc. specializes in the development of nucleic acid-based therapeutics aimed at targeting specific sequences in genetic code, with a focus on treating rare diseases. Founded in 2018 and located in Cambridge, Massachusetts, the company utilizes a proprietary platform that enables efficient and selective RNA editing by leveraging natural processes found in multi-cellular organisms. This innovative approach allows Korro Bio to edit messenger RNA and recode specific codons, facilitating targeted modifications in protein structure and function across various tissues.

Maisonette

Series B in 2020
Maisonette Inc. operates an online marketplace specializing in baby and child products. Founded in 2016 and headquartered in Brooklyn, New York, the company curates a selection of high-quality children's items sourced from renowned designer brands and unique boutiques worldwide. By focusing on an expertly curated shopping experience, Maisonette aims to provide a superior platform for both consumers seeking premium children's products and smaller retailers looking to reach a broader audience.

Akouos

Series B in 2020
Akouos is a biotechnology company focusing on restoring and preserving hearing. The company leverages adeno-associated viral (AAV) vector-based gene therapy in order to restore and preserve hearing in genetically-defined patient populations in a range of forms, from a single genetic mutation to ototoxic drug exposure and to the aging process, enabling the healthcare industry to treat sensorineural hearing loss in an efficient manner.

ZeroFox

Series D in 2020
ZeroFox is a cybersecurity company based in Baltimore, Maryland, that specializes in protecting organizations from threats arising from social networking and digital communication platforms. The company offers a range of solutions, including real-time social threat analytics, intelligence, and advanced security protection through its cloud-based platform. Its products, such as the ZeroFOX intelligence Livefeed and Protection Cloud, help organizations proactively defend against malware, targeted attacks, and various forms of social engineering, including impersonation and fraud. Additionally, ZeroFox provides services aimed at safeguarding high-value employees and political candidates from targeted threats. The company serves diverse industries, including financial services, healthcare, and technology, by continuously monitoring social media for cyber attacks and information loss. Founded in 2013, ZeroFox has received multiple industry accolades for its innovative approach to cybersecurity.

Moda Operandi

Venture Round in 2020
Moda Operandi, Inc. is an online retailer specializing in fashion products, including clothing, shoes, bags, jewelry, and home goods for men, women, and children. The company features an e-commerce platform that connects consumers with both established and emerging fashion designers worldwide. It offers unique shopping experiences through online designer trunk shows, allowing customers to preorder items directly from designers. Moda Operandi boasts a diverse portfolio of over 1,000 designers and maintains a global network of physical showrooms and personal stylists. The company ships products to more than 125 countries, enhancing its international reach. Founded in 2010 and headquartered in New York, Moda Operandi was initially named Trunk Show Inc. before rebranding in August 2010.

Moda Operandi

Debt Financing in 2020
Moda Operandi, Inc. is an online retailer specializing in fashion products, including clothing, shoes, bags, jewelry, and home goods for men, women, and children. The company features an e-commerce platform that connects consumers with both established and emerging fashion designers worldwide. It offers unique shopping experiences through online designer trunk shows, allowing customers to preorder items directly from designers. Moda Operandi boasts a diverse portfolio of over 1,000 designers and maintains a global network of physical showrooms and personal stylists. The company ships products to more than 125 countries, enhancing its international reach. Founded in 2010 and headquartered in New York, Moda Operandi was initially named Trunk Show Inc. before rebranding in August 2010.
Black Diamond Therapeutics is a precision oncology medicine company focused on discovering and developing small molecule, tumor-agnostic therapies. The company's lead product candidate, BDTX-189, is designed to inhibit specific mutations in ErbB kinases, including the epidermal growth factor receptor. Additionally, Black Diamond is advancing a pipeline of allosteric-EGFR mutation inhibitors and other early-stage programs targeting allosteric mutations in kinases associated with cancer and rare genetic diseases. The company employs a technology platform known as Mutation-Allostery-Pharmacology, which aims to address undrugged mutations in patients with genetically defined cancers. Founded in 2014 and based in Cambridge, Massachusetts, Black Diamond Therapeutics was previously known as ASET Therapeutics until its rebranding in 2018.

Flow Commerce

Series B in 2019
Flow provides a turn-key platform for e-commerce companies to go global, capturing international demand for their products. The platform enables merchants to simply configure their cross-border supply-chain requirements and immediately fulfill their overseas demand. Flow can be used by e-commerce companies of any size and both as a complete, end-to-end solution or as a modular unbundled product. Using the Flow platform the experience of buying and selling internationally is as easy as domestic for both merchants and consumers.

Neural Magic

Seed Round in 2019
Neural Magic is unlocking the possibility of machine learning, by re-imagining how deep learning is done. A team of pioneers, we believe machine learning has the potential to alter the trajectory of human history. Break free of limitations. Be a part of the future.

Neural Magic

Seed Round in 2019
Neural Magic is unlocking the possibility of machine learning, by re-imagining how deep learning is done. A team of pioneers, we believe machine learning has the potential to alter the trajectory of human history. Break free of limitations. Be a part of the future.

Upskill

Venture Round in 2019
Upskill provides wearable technology to connect hands-on workers from the factory to the warehouse to the jobsite. Its robust platform, Skylight, connects the industrial workforce with the people, processes, information, and equipment they need to do their jobs with greater efficiency and fewer errors, leaving them hands free to focus on their tasks at hand, and their tools. For organizations in the competitive global market looking to increase productivity, improve quality, reduce costs, train new workers, retain tribal knowledge, and provide a strong foundation for further investments, the future starts with Upskill.

IonQ

Series B in 2019
IonQ, Inc. specializes in the development of general-purpose quantum information computers, utilizing a unique trapped ion approach. The company's technology combines high physical performance, perfect qubit replication, and optical networkability, enabling the creation of scalable quantum computers that surpass the limitations of classical computing. These advancements leverage phenomena such as superposition and entanglement, which are critical at the atomic scale. Founded in 2015 and headquartered in College Park, Maryland, IonQ aims to support a wide range of applications across various industries with its powerful and versatile quantum computing solutions.

Arcellx

Series B in 2019
Arcellx is a privately held development-stage company founded in 2015 and located in Montgomery County, Maryland. The Arcellx team is devoted to providing patients with superior immune cell therapies through scientific innovation, accelerated development, and responsible patient care. Although our initial clinical focus is cancer therapy, we are committed to extending our Antigen- Receptor Complex T cell (ARC-T) therapies across a broad spectrum of human disease.

Expel

Series C in 2019
Expel, Inc. is a managed security software company that specializes in providing SOC-as-a-service, which includes security monitoring and response for cloud, hybrid, and on-premises environments. Founded in 2016 and based in Herndon, Virginia, Expel leverages existing security signals from its customers to enhance the value of their current security investments. By connecting to customer technology remotely via APIs rather than agents, Expel can initiate monitoring within hours, allowing internal teams to concentrate on their unique security priorities. The company aims to streamline and improve the security operations of organizations, enabling them to respond effectively to emerging threats.

Tamara Mellon

Series C in 2019
Tamara Mellon, LLC offers apparel and accessories for women. It offers shoes, including sandals, boots, pumps, flats, and legging boots; bags and accessories; and ready to wear solutions, such as dresses, jumpsuits and rompers, tops and knitwear, pants and skirts, and jackets and outerwear. The company sells its products through retail and online stores in the United States and internationally. Tamara Mellon, LLC was incorporated in 2011 and is headquartered in New York, New York.

Block Renovation

Series A in 2019
Block Renovation is a renovation platform that combines architect-grade design, construction labor, and materials into a streamlined renovation experience. Block’s mission is to give homeowners a better way to improve the spaces they live in, and to give contractors a better way to work. Founded by Koda Wang and Luke Sherwin, Block simplifies a complex and convoluted process and delivers an intuitive experience for completing a beautiful home renovation.

Evident

Series B in 2019
Evident ID Inc. develops software for online identity reliability investigation providing limited disclosure of verified information about a user to a recipient for the purpose of enabling an electronic or physical interaction. It offers services in the areas of identity verification, background checks, criminal history and watch lists, drivers’ record checks, professional licenses, drug tests and medical records, address verifications, and business entity. Evident ID Inc. was incorporated in 2015 and is based in Atlanta, Georgia.

THE WELL

Series A in 2019
THE WELL is a modern membership-based wellness club designed for busy urban professionals. They bring together Western doctors and Eastern healers to collaborate, developing online content and personalized products and experiences that empower their community to take greater agency for their health. The company recognizes both the benefits of Western medicine and the wisdom of Eastern healing and have built a science-backed ecosystem for wellness. The Well's integrative medicine doctors, health coaches, and skilled practitioners work together under one roof to build customized plans uniquely suited to each member and their goals.

Inozyme

Series A in 2019
Inozyme Pharma, Inc. is a biopharmaceutical company focused on developing therapies for rare diseases related to abnormal mineralization affecting the vasculature, soft tissue, and skeletal systems. The company's lead product candidate, INZ-701, is a recombinant protein designed to treat rare genetic conditions caused by ENPP1 and ABCC6 deficiencies, as well as calciphylaxis. Inozyme's therapies aim to address the underlying causes of these debilitating diseases, providing potentially disease-modifying treatments for conditions such as Generalized Arterial Calcification of Infancy and Autosomal Recessive Hypophosphatemic Rickets Type 2. The company has a licensing agreement with Yale University for certain therapeutic applications and is headquartered in Boston, Massachusetts. Established in 2015, Inozyme is dedicated to improving the quality of life for patients affected by severe metabolic disorders associated with mineral imbalances.

Casper

Series D in 2019
Casper Sleep Inc. is a company that designs and sells a variety of sleep products, including mattresses, pillows, sheets, duvets, and sleep accessories, to consumers in the United States, Canada, and Europe. Originally founded in 2013 as Providence Mattress Company, the business rebranded in 2014 and has since developed its products in-house by leveraging the expertise of product engineers. Casper aims to provide quality sleep solutions by selling directly to consumers through its e-commerce platform, 60 retail stores, and various retail partners, thereby eliminating inflated prices associated with commission-driven sales. In addition to its core offerings, Casper has expanded its product line to include bedroom furniture and sleep technology, catering to a diverse range of customer needs. The company is headquartered in New York, New York.

Landit

Series A in 2019
Landit is a technology platform that increases the success and engagement of women and diverse groups in the workplace. The market leader in personalized career pathing, Landit creates a turnkey “one size fits one” solution that enables enterprises to attract, develop, and retain high-potential diverse talent. Landit provides each member with a personalized playbook that empowers them with the tools, resources, know-how, and human connections they need to advance and navigate their career path. Key features include building a personal brand, executive coaching, creating a personal board of advisors, curated skill development and mapping to career opportunities.

Dandelion

Series A in 2019
Dandelion's vision is to enable frictionless discovery of content and commerce. In a world where its easy for anyone to be a seller, it should be easy for anyone to be a marketer too. Dandelion provides the platform to storefronts, marketplaces, and their participants to make that happen.

Aetion

Series B in 2019
Aetion, Inc. develops a science and analytics platform to assess real-world evidence (RWE) from a range of sources. The company offers Aetion Evidence Platform, a platform that generates RWE needed by healthcare decision makers to engage in value-based care. Its solution allows payers, providers, medical device makers, biopharma customers, and academic institutions to analyze data from various clinical and financial interactions in healthcare, including claims, electronic health records, registries, and clinical trials. The company’s platform is also used in database analytics and comparative effectiveness courses taken by epidemiologists, outcomes researchers, health economists, and biostatisticians. It serves customers worldwide. Aetion, Inc. has a strategic collaboration with McKesson. The company was founded in 2012 and is based in New York, New York.

Knotch

Series B in 2019
Knotch, Inc. is an independent provider of real-time intelligence focused on digital marketing. Founded in 2012 and based in San Francisco, Knotch offers a software-as-a-service (SaaS) platform that enables brands to connect their content to specific business outcomes. The Knotch intelligence suite equips marketers with the tools needed to access performance data and consumer sentiment insights, allowing for comprehensive analysis and optimization of content strategies. By providing metrics, benchmarks, and insights, Knotch supports brands in planning, measuring, and enhancing their marketing efforts across both owned and paid channels.
Black Diamond Therapeutics is a precision oncology medicine company focused on discovering and developing small molecule, tumor-agnostic therapies. The company's lead product candidate, BDTX-189, is designed to inhibit specific mutations in ErbB kinases, including the epidermal growth factor receptor. Additionally, Black Diamond is advancing a pipeline of allosteric-EGFR mutation inhibitors and other early-stage programs targeting allosteric mutations in kinases associated with cancer and rare genetic diseases. The company employs a technology platform known as Mutation-Allostery-Pharmacology, which aims to address undrugged mutations in patients with genetically defined cancers. Founded in 2014 and based in Cambridge, Massachusetts, Black Diamond Therapeutics was previously known as ASET Therapeutics until its rebranding in 2018.

Tiburio Therapeutics

Series A in 2019
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.The company's compounds aid in the treatment of non-functioning pituitary adenoma using a dopamine-somatostatin chimeric molecule that has the potential to shrink or halt tumor growth, providing patients with effective treatment for rare neuroendocrine tumors and endocrine diseases.

Trevi Therapeutics

Series C in 2019
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in New Haven, Connecticut, dedicated to developing and commercializing nalbuphine ER, an investigational therapy. The company's lead product, Haduvio, is an oral extended-release formulation of nalbuphine currently undergoing Phase IIb/III clinical trials. Trevi Therapeutics is focused on addressing serious neurologically mediated conditions, including chronic pruritus, chronic cough associated with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in Parkinson's disease patients. The ongoing PRISM trial evaluates Haduvio's effectiveness in treating severe pruritus related to prurigo nodularis, highlighting its potential in managing conditions linked by a common pathophysiology involving opioid receptors in the nervous system. Founded in 2011, Trevi Therapeutics aims to provide innovative therapeutic solutions for patients with significant unmet medical needs.

Transfix

Series D in 2018
Transfix, Inc. is a prominent trucking brokerage service provider based in New York, offering digital solutions for freight transportation in the United States. Established in 2010, the company has developed an application that connects shippers with a network of contracted carriers, enabling real-time shipment tracking and performance insights. Transfix serves various industries, including retail, food, beverage, and manufacturing, delivering competitive pricing and reliable service. By leveraging deep industry knowledge and advanced logistics software, Transfix aims to optimize supply chains for its clients. The company has gained recognition for its innovative approach, with notable partnerships that include several top retailers and major food and beverage brands in America.

Block Renovation

Seed Round in 2018
Block Renovation is a renovation platform that combines architect-grade design, construction labor, and materials into a streamlined renovation experience. Block’s mission is to give homeowners a better way to improve the spaces they live in, and to give contractors a better way to work. Founded by Koda Wang and Luke Sherwin, Block simplifies a complex and convoluted process and delivers an intuitive experience for completing a beautiful home renovation.

WireWheel

Series A in 2018
WireWheel, Inc. is a software company that specializes in data privacy management, offering a cloud-based platform designed to assist organizations in complying with various data protection regulations, such as the EU GDPR, Privacy Shield, PCI DSS, and HIPAA. Founded in 2016 and headquartered in Arlington, Virginia, WireWheel's platform provides tools for privacy program management and subject rights request management. By integrating machine learning and data science, the platform helps companies automate the mapping of their public cloud assets and manage third-party relationships. This capability enables organizations to effectively address their compliance obligations while maximizing the potential of their data assets, ultimately enhancing their competitive advantage in the market.

Enigma

Series C in 2018
Enigma Technologies, Inc. is a New York-based operational data management and intelligence company that offers a comprehensive searchable database of public records and documents. Its core offerings include Enigma Data Infrastructure, which encompasses tools for data operations and search capabilities, and Enigma Solutions, tailored products and services for industries such as financial services, healthcare, and insurance. The company provides analysis-ready public data and operates Enigma Labs to develop open data tools for public use. Additionally, Enigma offers an application programming interface (API) to facilitate application development and various data services, including entity resolution and custom data acquisition. By delivering timely and accurate insights into small businesses' identities and risk profiles, Enigma supports organizations like American Express and PayPal in making informed operational decisions. Founded in 2011, Enigma continues to bridge the gap between data and workflows, enhancing decision-making processes across sectors.

Masse

Seed Round in 2018
Masse is a mobile app which recommends products from people you trust.

Trevi Therapeutics

Series C in 2018
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in New Haven, Connecticut, dedicated to developing and commercializing nalbuphine ER, an investigational therapy. The company's lead product, Haduvio, is an oral extended-release formulation of nalbuphine currently undergoing Phase IIb/III clinical trials. Trevi Therapeutics is focused on addressing serious neurologically mediated conditions, including chronic pruritus, chronic cough associated with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in Parkinson's disease patients. The ongoing PRISM trial evaluates Haduvio's effectiveness in treating severe pruritus related to prurigo nodularis, highlighting its potential in managing conditions linked by a common pathophysiology involving opioid receptors in the nervous system. Founded in 2011, Trevi Therapeutics aims to provide innovative therapeutic solutions for patients with significant unmet medical needs.

Akouos

Series A in 2018
Akouos is a biotechnology company focusing on restoring and preserving hearing. The company leverages adeno-associated viral (AAV) vector-based gene therapy in order to restore and preserve hearing in genetically-defined patient populations in a range of forms, from a single genetic mutation to ototoxic drug exposure and to the aging process, enabling the healthcare industry to treat sensorineural hearing loss in an efficient manner.

Catalog

Seed Round in 2018
CATALOG is a developer of a data conversion and storage platform used to offer the next generation of digital data archives and computation. Its platform facilitates the encoding of data and information into DNA format and makes it economically attractive to use DNA as the major medium for long-term archival of data that enables customers to store digital information in DNA molecules. It brings cutting-edge synthetic biology technologies to the world of information storage and computation. The company was founded in 2016 and is headquartered in Boston, Massachusetts.

Maisonette

Series A in 2018
Maisonette Inc. operates an online marketplace specializing in baby and child products. Founded in 2016 and headquartered in Brooklyn, New York, the company curates a selection of high-quality children's items sourced from renowned designer brands and unique boutiques worldwide. By focusing on an expertly curated shopping experience, Maisonette aims to provide a superior platform for both consumers seeking premium children's products and smaller retailers looking to reach a broader audience.

Dreams

Series A in 2018
Dreams is a mobile-only TV platform that redesigns TV for the most important device. Dreams developed patent-pending computer vision technology to create a modern, mobile-first TV news experience. The company’s software converts live TV news into a vertical video format in real-time, enabling the first-ever live, 24/7 vertical video news channels. Dreams is available for free in the U.S. on the App Store and Google Play. The app requires no login or registration. It was founded in New York City in 2016 by Tom Bender and Greg Hochmuth.

Choosy

Seed Round in 2018
Choosy is an on-demand social shopping platform where users influence every collection to match their favorite style inspirations. Through social tagging and a team of Style Scouts, Choosy identifies and manufactures trend-driven fashion delivered to shoppers in as little as two weeks. It’s the modern-day equivalent of the ultimate window-shopping experience, creating a new generation of social commerce. All looks are designed and produced in-house, so women sizes 0-20 can get today’s most covetable looks without the ticket price of labels. You see it, you like it, we make it - it’s time to #GetChoosy with your wardrobe.

Tamara Mellon

Series B in 2018
Tamara Mellon, LLC offers apparel and accessories for women. It offers shoes, including sandals, boots, pumps, flats, and legging boots; bags and accessories; and ready to wear solutions, such as dresses, jumpsuits and rompers, tops and knitwear, pants and skirts, and jackets and outerwear. The company sells its products through retail and online stores in the United States and internationally. Tamara Mellon, LLC was incorporated in 2011 and is headquartered in New York, New York.

Aetion

Series B in 2018
Aetion, Inc. develops a science and analytics platform to assess real-world evidence (RWE) from a range of sources. The company offers Aetion Evidence Platform, a platform that generates RWE needed by healthcare decision makers to engage in value-based care. Its solution allows payers, providers, medical device makers, biopharma customers, and academic institutions to analyze data from various clinical and financial interactions in healthcare, including claims, electronic health records, registries, and clinical trials. The company’s platform is also used in database analytics and comparative effectiveness courses taken by epidemiologists, outcomes researchers, health economists, and biostatisticians. It serves customers worldwide. Aetion, Inc. has a strategic collaboration with McKesson. The company was founded in 2012 and is based in New York, New York.

Expel

Series B in 2018
Expel, Inc. is a managed security software company that specializes in providing SOC-as-a-service, which includes security monitoring and response for cloud, hybrid, and on-premises environments. Founded in 2016 and based in Herndon, Virginia, Expel leverages existing security signals from its customers to enhance the value of their current security investments. By connecting to customer technology remotely via APIs rather than agents, Expel can initiate monitoring within hours, allowing internal teams to concentrate on their unique security priorities. The company aims to streamline and improve the security operations of organizations, enabling them to respond effectively to emerging threats.

CoEdition

Seed Round in 2018
CoEdition, Inc. operates as an online retailer of women’s clothing items, shoes, and jewelry. It offers dresses, swimwear, footwear, clothing, lingerie, and accessories. CoEdition, Inc. was formerly known as Frigg, Inc. and changed its name to CoEdition, Inc. in November 2017. The company was incorporated in 2017 and is headquartered in New York, New York.

Upskill

Corporate Round in 2018
Upskill provides wearable technology to connect hands-on workers from the factory to the warehouse to the jobsite. Its robust platform, Skylight, connects the industrial workforce with the people, processes, information, and equipment they need to do their jobs with greater efficiency and fewer errors, leaving them hands free to focus on their tasks at hand, and their tools. For organizations in the competitive global market looking to increase productivity, improve quality, reduce costs, train new workers, retain tribal knowledge, and provide a strong foundation for further investments, the future starts with Upskill.

Greenlight

Series A in 2018
Greenlight Financial Technology, Inc. is a financial services company that offers debit card solutions designed specifically for children, enabling parents to instill financial literacy from an early age. Founded in 2014 and headquartered in Atlanta, Georgia, Greenlight provides a mobile application that allows parents to manage their children’s spending by designating specific stores where the Greenlight debit card can be used. This patent-pending technology empowers families to create teachable moments around earning, saving, spending, and giving. By focusing on convenience and safety, Greenlight aims to help parents raise financially savvy children while also expanding its network across the United States.

Liquidia Technologies

Series D in 2018
Liquidia Technologies is a late-stage clinical biopharmaceutical company based in Morrisville, North Carolina, that specializes in the development and commercialization of human therapeutics. The company utilizes its proprietary PRINT technology, a particle engineering platform that allows for the precise production of uniform drug particles, aimed at improving the safety, efficacy, and performance of various therapies. Liquidia is currently advancing two key product candidates: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for addressing local post-operative pain. In addition to its internal pipeline, Liquidia collaborates with leading pharmaceutical companies to leverage its PRINT technology across multiple therapeutic areas and drug types. The company also offers strategy and commercialization services for rare disease pharmaceutical products, including a generic formulation of treprostinil for pulmonary arterial hypertension. Founded in 2004, Liquidia Technologies continues to focus on transforming patient care through innovative therapeutic solutions.

Vizbee

Venture Round in 2018
Vizbee Inc. XYZ operates in the technology industry. The company was founded in 2014 and is based in New York, New York.

FINERY

Seed Round in 2018
They are a Fashion/Technology startup that is busy making an OS that will revolutionize the way you interact with your wardrobe.
Personal Genome Diagnostics develops a patient-specific analysis of the cancer genome by using advanced tools and technologies. They were the first to sequence and analyze whole human cancer exomes and subsequently identified many alterations responsible for the development of cancer. They have described the principles underlying the genetic basis of human cancer and have developed novel technologies for non-invasive “liquid biopsy” approaches in cancer. Through PGDx, our founders bring their proprietary methods and expertise to research teams worldwide. The services help oncologists and translational scientists sequence and analyze cancer genomes and identify mutations to characterize aspects of the disease. Their expertise in genome analysis ranges from sample preparation and sequencing to data interpretation and analysis. They specialize in high-throughput next-generation sequencing and proprietary algorithms to identify alterations in complex cancer genomes and have developed novel technologies for non-invasive “liquid biopsy” approaches in cancer. Personal Genome Diagnostics was founded in 2010 and is based in Baltimore, Maryland, United States.

Centrexion Therapeutics

Series D in 2018
Centrexion Therapeutics Corporation is a late clinical-stage biopharmaceutical company dedicated to developing novel, non-opioid, and non-addictive therapies for chronic pain management. Founded in 2013 and based in Boston, Massachusetts, the company’s product pipeline includes CNTX-4975, currently undergoing Phase III trials for knee osteoarthritis pain and Phase II trials for Morton’s neuroma and canine osteoarthritis. Additionally, CNTX-0290 is in Phase I trials for various chronic pain conditions, while CNTX-6970 targets inflammatory pain and CNTX-2022, a high-concentration topical gel formulation of lidocaine, is also in Phase I trials for superficial musculoskeletal pain and related conditions. Furthermore, CNTX-6016 is a pre-clinical candidate aimed at treating chronic neuropathic pain. Centrexion Therapeutics is committed to addressing the unmet medical needs in chronic pain treatment by focusing on safety and efficacy.

Retrieve

Venture Round in 2018
We offer a fully collaborative, modern digital experience for learning and communication. The Retrieve platform can be used by both education and enterprise clients. Teach and maintain courses, conduct student assessments. Communicate live or asynchronously via web conferences, discussion boards, and chat to students or remote employees. Share notes, files or images, distribute technical manuals, user guides and other documentation.

Korro Bio

Seed Round in 2018
Korro Bio Inc. specializes in the development of nucleic acid-based therapeutics aimed at targeting specific sequences in genetic code, with a focus on treating rare diseases. Founded in 2018 and located in Cambridge, Massachusetts, the company utilizes a proprietary platform that enables efficient and selective RNA editing by leveraging natural processes found in multi-cellular organisms. This innovative approach allows Korro Bio to edit messenger RNA and recode specific codons, facilitating targeted modifications in protein structure and function across various tissues.

Akouos

Seed Round in 2017
Akouos is a biotechnology company focusing on restoring and preserving hearing. The company leverages adeno-associated viral (AAV) vector-based gene therapy in order to restore and preserve hearing in genetically-defined patient populations in a range of forms, from a single genetic mutation to ototoxic drug exposure and to the aging process, enabling the healthcare industry to treat sensorineural hearing loss in an efficient manner.

Inozyme

Series A in 2017
Inozyme Pharma, Inc. is a biopharmaceutical company focused on developing therapies for rare diseases related to abnormal mineralization affecting the vasculature, soft tissue, and skeletal systems. The company's lead product candidate, INZ-701, is a recombinant protein designed to treat rare genetic conditions caused by ENPP1 and ABCC6 deficiencies, as well as calciphylaxis. Inozyme's therapies aim to address the underlying causes of these debilitating diseases, providing potentially disease-modifying treatments for conditions such as Generalized Arterial Calcification of Infancy and Autosomal Recessive Hypophosphatemic Rickets Type 2. The company has a licensing agreement with Yale University for certain therapeutic applications and is headquartered in Boston, Massachusetts. Established in 2015, Inozyme is dedicated to improving the quality of life for patients affected by severe metabolic disorders associated with mineral imbalances.

WireWheel

Seed Round in 2017
WireWheel, Inc. is a software company that specializes in data privacy management, offering a cloud-based platform designed to assist organizations in complying with various data protection regulations, such as the EU GDPR, Privacy Shield, PCI DSS, and HIPAA. Founded in 2016 and headquartered in Arlington, Virginia, WireWheel's platform provides tools for privacy program management and subject rights request management. By integrating machine learning and data science, the platform helps companies automate the mapping of their public cloud assets and manage third-party relationships. This capability enables organizations to effectively address their compliance obligations while maximizing the potential of their data assets, ultimately enhancing their competitive advantage in the market.

ThreatQuotient

Series C in 2017
ThreatQuotient is a threat intelligence platform (TIP) that centrally manages and correlates unlimited external sources with all internal security and analytics solutions for contextual, operationalized intelligence in a single pane of glass. ThreatQ is also the first TIP to provide Indicator Nurturing, which goes beyond enrichment to help customers tailor indicators of compromise (IOCs) more specifically to their infrastructure. Headquartered in Northern Virginia, ThreatQuotient was founded in 2013 by two former security operations analysts to provide organizations the ability to correlate with confidence.

Feather

Seed Round in 2017
Feather provides furniture and home decor rental service The company helps city dwellers to furnish their homes without spending a fortune or hurting the planet in the process. Members of Feather have access to high-quality furniture at a low monthly price with the option to add, swap, buy, or return when life or tastes change. Furniture is delivered and assembled for free within a week. Feather’s circular approach reduces the environmental impact that furniture waste has on the planet by keeping furniture in homes and out of landfills.

Cydan

Venture Round in 2017
Cydan Development, Inc. is a company focused on the development and commercialization of therapies for orphan and rare diseases, with a particular emphasis on rare genetic disorders. Founded in 2012 and located in Lincoln, Massachusetts, Cydan functions as an orphan drug accelerator, identifying and de-risking compounds with therapeutic potential. The organization conducts comprehensive studies to support the further development of treatments by biotechnology firms. Cydan has worked on therapies for conditions such as Niemann-Pick Disease Type C and IMR-687 for sickle cell disease. The company leverages strong relationships with academic institutions and patient advocacy groups, along with deep expertise in drug development, to foster successful product commercialization and advance treatment options for underserved patient populations.

Wheels Up

Private Equity Round in 2017
Wheels Up is a membership-based private aviation company that focuses on reducing the upfront cost to fly privately, providing flexibility, service, and safety. Its mobile app enables members to book flights, manage their accounts, and participate in ride-share opportunities. Its members also have given access to the Wheels Down program. The company was founded in 2013 and headquartered in New York, United States.

BrandShield

Venture Round in 2017
BrandShield® is an innovative Online Brand Protection solution. It's robust, patented technology finds trademark infringements, counterfeit sales and online phishing and fraud. The system analyzes content and metrics of each website, marketplace or social platform, and uses sophisticated algorithms to automatically prioritize the level of risk to the brand. BrandShield's ground breaking pattern recognition technology finds major brand threats. It also includes enforcement tools and service, to form a powerfull Threat Intelligence solution. BrandShield's robust, patent pending technology helps fighting infringements and makes brand protection possible for all sizes of organizations. BrandShield's A-Z solution protects the brand from detection of threats to their takedown. Brandshield's proactive aproach extends any organization's assets protection outside the organization's perimeter. BrandShield detects logo usage online, fraud clusters, cross-platform connections and prioritizes online threats customized uniqely for each brand. BrandShied's technology dramatically improves the way organizations can manage and protect their digital brand. Till now online brand protection solutions were limited, based on human analysis, highly expensive, and therefore available only to the biggest companies. BrandShield's technology revolutionizes this market, and will allow every business to monitor and protect its brand online, at a reasonable cost. Brandshield's website - http://www.brandshield.com/

Wheels Up

Series C in 2017
Wheels Up is a membership-based private aviation company that focuses on reducing the upfront cost to fly privately, providing flexibility, service, and safety. Its mobile app enables members to book flights, manage their accounts, and participate in ride-share opportunities. Its members also have given access to the Wheels Down program. The company was founded in 2013 and headquartered in New York, United States.

Evident

Series A in 2017
Evident ID Inc. develops software for online identity reliability investigation providing limited disclosure of verified information about a user to a recipient for the purpose of enabling an electronic or physical interaction. It offers services in the areas of identity verification, background checks, criminal history and watch lists, drivers’ record checks, professional licenses, drug tests and medical records, address verifications, and business entity. Evident ID Inc. was incorporated in 2015 and is based in Atlanta, Georgia.

IonQ

Series A in 2017
IonQ, Inc. specializes in the development of general-purpose quantum information computers, utilizing a unique trapped ion approach. The company's technology combines high physical performance, perfect qubit replication, and optical networkability, enabling the creation of scalable quantum computers that surpass the limitations of classical computing. These advancements leverage phenomena such as superposition and entanglement, which are critical at the atomic scale. Founded in 2015 and headquartered in College Park, Maryland, IonQ aims to support a wide range of applications across various industries with its powerful and versatile quantum computing solutions.

Trevi Therapeutics

Series C in 2017
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in New Haven, Connecticut, dedicated to developing and commercializing nalbuphine ER, an investigational therapy. The company's lead product, Haduvio, is an oral extended-release formulation of nalbuphine currently undergoing Phase IIb/III clinical trials. Trevi Therapeutics is focused on addressing serious neurologically mediated conditions, including chronic pruritus, chronic cough associated with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in Parkinson's disease patients. The ongoing PRISM trial evaluates Haduvio's effectiveness in treating severe pruritus related to prurigo nodularis, highlighting its potential in managing conditions linked by a common pathophysiology involving opioid receptors in the nervous system. Founded in 2011, Trevi Therapeutics aims to provide innovative therapeutic solutions for patients with significant unmet medical needs.

Desktop Metal

Series D in 2017
Desktop Metal, Inc. specializes in additive manufacturing solutions tailored for engineers, designers, and manufacturers across various industries, including automotive, aerospace, healthcare, and consumer products. Founded in 2015 and headquartered in Burlington, Massachusetts, the company offers several products, such as the Production System for industrial manufacturing, the Shop System for machine and job shops, the Studio System for office environments, and Fiber, a desktop 3D printer. By focusing on the entire production process from prototyping to mass production, Desktop Metal aims to transform how metal parts are designed and manufactured. The company has secured significant equity funding from notable investors, which has helped build a team of experts in materials science, hardware and software engineering, and design.

Catalog

Seed Round in 2017
CATALOG is a developer of a data conversion and storage platform used to offer the next generation of digital data archives and computation. Its platform facilitates the encoding of data and information into DNA format and makes it economically attractive to use DNA as the major medium for long-term archival of data that enables customers to store digital information in DNA molecules. It brings cutting-edge synthetic biology technologies to the world of information storage and computation. The company was founded in 2016 and is headquartered in Boston, Massachusetts.

Transfix

Series C in 2017
Transfix, Inc. is a prominent trucking brokerage service provider based in New York, offering digital solutions for freight transportation in the United States. Established in 2010, the company has developed an application that connects shippers with a network of contracted carriers, enabling real-time shipment tracking and performance insights. Transfix serves various industries, including retail, food, beverage, and manufacturing, delivering competitive pricing and reliable service. By leveraging deep industry knowledge and advanced logistics software, Transfix aims to optimize supply chains for its clients. The company has gained recognition for its innovative approach, with notable partnerships that include several top retailers and major food and beverage brands in America.

Casper

Series C in 2017
Casper Sleep Inc. is a company that designs and sells a variety of sleep products, including mattresses, pillows, sheets, duvets, and sleep accessories, to consumers in the United States, Canada, and Europe. Originally founded in 2013 as Providence Mattress Company, the business rebranded in 2014 and has since developed its products in-house by leveraging the expertise of product engineers. Casper aims to provide quality sleep solutions by selling directly to consumers through its e-commerce platform, 60 retail stores, and various retail partners, thereby eliminating inflated prices associated with commission-driven sales. In addition to its core offerings, Casper has expanded its product line to include bedroom furniture and sleep technology, catering to a diverse range of customer needs. The company is headquartered in New York, New York.

Greenlight

Seed Round in 2017
Greenlight Financial Technology, Inc. is a financial services company that offers debit card solutions designed specifically for children, enabling parents to instill financial literacy from an early age. Founded in 2014 and headquartered in Atlanta, Georgia, Greenlight provides a mobile application that allows parents to manage their children’s spending by designating specific stores where the Greenlight debit card can be used. This patent-pending technology empowers families to create teachable moments around earning, saving, spending, and giving. By focusing on convenience and safety, Greenlight aims to help parents raise financially savvy children while also expanding its network across the United States.

Blispay

Venture Round in 2017
Blispay Inc. is a financial technology company based in Baltimore, Maryland, that specializes in providing mobile payment solutions and point-of-sale financing for small and midsize retailers. Founded in 2014, Blispay offers a mobile-centric credit card that allows merchants to provide financing options to their customers without the need for technical integration or financial obligations. The Blispay Visa Card features instant issuance, six months of special financing, and a cash-back incentive, making it an attractive option for both retailers and consumers. The company's founding team includes industry veterans with backgrounds from notable organizations, enhancing its capability to deliver innovative financial products that meet the needs of modern shoppers and merchants alike.

Synlogic

Series C in 2017
Synlogic, Inc. is a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, specializing in the discovery and development of synthetic biotic medicines aimed at treating metabolic, inflammatory, and cancer-related diseases. The company’s lead therapeutic program, SYNB1618, is an oral therapy currently in Phase I/IIa clinical trials for the treatment of phenylketonuria. Additionally, Synlogic is developing SYNB1891, an intratumoral synthetic biotic medicine that is undergoing Phase I clinical trials for the treatment of solid tumors and lymphoma. The company is also exploring synthetic biotics for more common conditions, including inflammatory bowel disease and secondary hyperoxaluria. Synlogic has established a collaboration with Ginkgo Bioworks to advance its development of these innovative therapies.

Upskill

Series B in 2017
Upskill provides wearable technology to connect hands-on workers from the factory to the warehouse to the jobsite. Its robust platform, Skylight, connects the industrial workforce with the people, processes, information, and equipment they need to do their jobs with greater efficiency and fewer errors, leaving them hands free to focus on their tasks at hand, and their tools. For organizations in the competitive global market looking to increase productivity, improve quality, reduce costs, train new workers, retain tribal knowledge, and provide a strong foundation for further investments, the future starts with Upskill.

Maisonette

Seed Round in 2017
Maisonette Inc. operates an online marketplace specializing in baby and child products. Founded in 2016 and headquartered in Brooklyn, New York, the company curates a selection of high-quality children's items sourced from renowned designer brands and unique boutiques worldwide. By focusing on an expertly curated shopping experience, Maisonette aims to provide a superior platform for both consumers seeking premium children's products and smaller retailers looking to reach a broader audience.

Fam

Convertible Note in 2017
Fam's mission is to build products that revolutionize the way teens and millennials communicate. They believe in a calculated combination of live group video and group chat messaging to execute this. It is the world’s first group video chat app for iMessage, with over 7 million users. Their app instantly connects with the family and friends closest to its user through group video calling, right from their iPhone, and Android text message app.